Invitrogen, Applied Biosystems clear waiting period hurdle

By Lisa Kerner

Charlotte, N.C., July 29 - The Hart-Scott-Rodino waiting period expired in the pending merger of Invitrogen Corp. and Applera Corp.'s Applied Biosystems Inc., the companies announced on Tuesday.

A similar review process with the European Commission will begin soon.

In June, Invitrogen agreed to acquire Applera for $38 per share in a cash and stock transaction valued at $6.7 billion.

Invitrogen recently announced that the acquisition is expected to close in late October or early November.

The combined company will be named Applied Biosystems, Inc. and will have its corporate headquarters in Carlsbad, Calif.

Invitrogen global head of operations Mark Smedley is leading the integration of the two companies.

"Integration teams comprising all functional areas of both companies are now in place and operating at full speed," Smedley said in an Invitrogen news release. "We have a clear integration model in place and we are well on track to start delivering on the potential of our new company as soon as the transaction closes."

Invitrogen is a Carlsbad, Calif.-based provider of life science technologies for disease research, drug discovery and commercial bioproduction.

Applied Biosystems is a developer and marketer of instrument-based systems, consumables, software and services. The company is located in Norwalk, Conn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.